• Healthcare M&A update: Q2-2017

    The second quarter of 2017 showed positive performance for the broader U.S. equity market, as the S&P, DJIA and NASDAQ closed up 2.6 percent, 3.3 percent and 3.9 percent, respectively, for the quarter.
  • Life sciences M&A update: H1-2017

    Baker Tilly Capital, LLC's life sciences M&A newsletter provides an overview of the U.S. medical devices and products, pharmaceutical (pharma) and pharma outsourced services sectors, including recent performance and M&A trends.
  • Healthcare M&A update: Q1-2017

    The first quarter of 2017 showed positive performance for the broader U.S. equity market, as the S&P, DJIA and NASDAQ closed up 5.5 percent, 4.6 percent and 9.8 percent, respectively, for the quarter.
  • What’s my company worth

    The principles of intrinsic vs. instrumental value. Anything bought or sold has value, but what is value? Value is defined as being either intrinsic or instrumental.